Information  X 
Enter a valid email address

Ilika plc (IKA)

  Print          Annual reports

Friday 10 September, 2021

Ilika plc

Commencement of trading on OTCQX Best Market in US

RNS Number : 3258L
Ilika plc
10 September 2021

Ilika plc

("Ilika" or the "Company")


Commencement of trading on the OTCQX Best Market in the United States


Ilika (AIM: IKA), a pioneer in solid-state battery technology, is pleased to announce that trading in the Company's ordinary shares will begin today on the OTCQX Best Market ("OTCQX"), in the United States, under the ticker symbol "ILIKF". Ilika has upgraded to OTCQX from the Pink® market.


Trading on OTCQX is an important step for Ilika, in addition to the AIM listing it gives the business exposure to a wider audience of potential investors by easing cross-border trading for our US investors. By trading on the premium OTCQX, Ilika's shares will be available to US investors during US working hours and priced in US dollars and has the potential to increase liquidity in Ilika's shares on AIM. Ilika's shares will continue to trade on the London Stock Exchange's AIM market under the symbol "IKA".


Graeme Purdy, Ilika plc CEO commented, "We are very pleased to be graduating to the OTCQX Market. This will provide our valued US investors with greater liquidity and execution services through OTCQX. It will also help us to build our visibility among US investors."


For more information contact:


Ilika plc

Graeme Purdy, Chief Executive

Via Walbrook PR

Steve Boydell, Finance Director






Liberum Capital Limited (Nomad and Joint Broker)

Tel: 020 3100 2000

Andrew Godber, Cameron Duncan,


William Hall, Nikhil Varghese






Joh. Berenberg, Gossler & Co. KG (Joint Broker)

Tel: 020 3207 8700

Emily Morris, Detlir Elezi,


Alamgir Ahmed, Milo Bonser






Walbrook PR Ltd

Tel: 020 7933 8780 /  [email protected]

Lianne Cawthorne

Mob: 07584 391 303

Nick Rome

Mob: 07748 325 236

Tom Cooper

Mob: 0797 122 1972


This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact [email protected] or visit

RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.

a d v e r t i s e m e n t